FLFrank H. Lee

Frank H. Lee

*This is an algorithmically generated author record based on publicly available information.

Frank H. Lee has a total of 5 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Anesthesiologists as Genetic Counselors?

    by Frank H. Lee, Srinivasa N. Raja

    We thank Rosenberg et al. for their interest in our editorial1 on the potential role that anesthesiologists may have to play as genetic counselors in light of developments in the direct-to-consumer genetic testing market. We also appreciate these researchers noting the importance of malignant hyperthermia when discussing genetics in anesthesiology. The focus of the editorial was on pain genes; it was not meant to be comprehensive.

  • Should Anesthesiologists be Equipped as Genetic Counselors?

    by Frank H. Lee, Srinavasa N. Raja

    THE ever-expanding role of anesthesiologists may soon include genetic counseling. Like other medical specialties, since the completion of the Human Genome Project, anesthesiologists have placed much research and commercial interest in the development of pharmacogenomics. The promise of personalized medicine tailored to each patient's genetics has encouraged the exploration of various genes related to the practice of anesthesiology, with far-reaching implications.1–3


  • Knowledge and Attitudes of Adult Peruvian Women vis-à-vis Human Papillomavirus (HPV), Cervical Cancer, and the HPV Vaccine

    by Frank H. Lee, Valerie A. Paz-Soldan, Cesar Carcamo, Patricia J. Garcia

    To determine knowledge and attitudes of adult Peruvian women regarding the human papillomavirus (HPV), cervical cancer, and acceptability of the HPV vaccine. A 4-section survey was administered to 511 25- to 65-year-old Peruvian women living in 3 low-income districts in Lima. Knowledge of HPV, the HPV vaccine, cervical cancer, and the association between HPV and cervical cancer was low. Approximately two-thirds of the participants knew nothing about HPV, the vaccine, and cervical cancer. However, vaccine acceptability was very high: 90% indicated they would get vaccinated if the HPV vaccine was available. In addition, 58% of the population was willing to pay "something," versus nothing, to be vaccinated. Although their knowledge was limited, mid adult Peruvian women have a very high level of acceptance for the HPV vaccine. Efforts to educate the population about HPV and cervical cancer are warranted along with further studies exploring the reasons for high vaccination acceptability to help reduce the rate of cervical cancer.